TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Abbott Laboratories (NYSE: ABT) | Delayed: 115.51 +6.11 (5.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.40 | 52 Week High | $46.38 | |||
| Open | $112.65 | 52 Week Low | $36.00 | |||
| Day High | $116.22 | P/E | 77.01 | |||
| Day Low | $112.12 | EPS | $1.50 | |||
| Volume | 12,711,335 | |||||
